Latest Breaking News On - Genor biopharma - Page 2 : comparemela.com

G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib

- Pepper Bio will Gain Exclusive Rights for the Clinical Development, Regulatory Submissions, and Commercialization of Lerociclib in the US, Europe, Japan, and All Other Global Markets Excluding.

United statesGenor biopharmaSamantha dale strasserJack baileyCaitlin brownResearch triangle parkMerck digital sciences studioExchange commissionHead of business developmentCorporate communicationsGain exclusive rights for the clinical developmentNational medical products administrationTherapeutics incGain exclusive rightsClinical developmentRegulatory submissions

Pepper spices up pipeline with $135M deal for G1 s cancer drug

Pepper spices up pipeline with $135M deal for G1 s cancer drug
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Genor biopharmaMerck digital sciences studioMerck coPepper bioMerck digital sciences

G1 Therapeutics and Pepper Bio Ink Global License Agreement for Lerociclib

G1 Therapeutics and Pepper Bio Ink Global License Agreement for Lerociclib
hitconsultant.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hitconsultant.net Daily Mail and Mail on Sunday newspapers.

Genor biopharmaTherapeutics incMerck digital sciences studioShould knowPepper bioBio advances liver cancer treatmentSilverton partnersMerck digital sciencesChief executive officer

Comparing argenx (NASDAQ:ARGX) & Cyclo Therapeutics (NASDAQ:CYTH)

argenx (NASDAQ:ARGX – Get Free Report) and Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership. Institutional & Insider Ownership 52.8% of argenx shares are […]

United statesUnited kingdomNoord hollandBroteio pharmaGenor biopharma coCyclo therapeutics incBiowa incLeiden university medical centerLangone healthUniversity of texasZai labHoldings incShire international gmbGet free reportCyclo therapeuticsCyclo therapeutic

Analyzing argenx (NASDAQ:ARGX) & Immatics (NASDAQ:IMTX)

Immatics (NASDAQ:IMTX – Get Free Report) and argenx (NASDAQ:ARGX – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation. Valuation & Earnings This table compares Immatics and argenx’s top-line […]

United kingdomUnited statesNoord hollandBroteio pharmaUniversity of texasLeiden university medical centerCelgene corporationGenor biopharma coBiowa incMd anderson cancer centerLangone healthZai labShire international gmbHoldings incGet free reportGiven immatic